The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Practice pattern for patients receiving bevacizumab in metastatic breast cancer.
R. Veiga
No relevant relationships to disclose
G. Duran
No relevant relationships to disclose
M. J. Lamas
No relevant relationships to disclose
J. F. Cueva
No relevant relationships to disclose
B. Bernardez
No relevant relationships to disclose
T. Curiel
No relevant relationships to disclose
R. Lopez
No relevant relationships to disclose